PURPLE BIOTECH LTD. (PPBT) Total liabilities 2019–2022
PURPLE BIOTECH LTD. (PPBT) total liabilities at each fiscal year-end, per SEC filings.
$4.4MFY2022 · since FY2019: $6.8M → $4.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2022 | $4.4M | +2.7% |
| FY2021 | $4.3M | +2.3% |
| FY2020 | $4.2M | -38.0% |
| FY2019 | $6.8M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More PPBT financial trends
PPBT RevenuePPBT Net incomePPBT Net marginPPBT Gross profitPPBT Gross marginPPBT Operating incomePPBT Operating marginPPBT Operating cash flowPPBT Free cash flowPPBT Capital expendituresPPBT Return on equityPPBT Stock buybacksPPBT Dividends paidPPBT Total assetsPPBT Shareholders’ equityPPBT overview →